Details

Autor(en) / Beteiligte

• Dong, Jun
• Ng, Wai Tong
• Wong, Charlene H.L.
• Li, Ji-Shi
• Bollen, Heleen
• Chow, James C.H.
• Eisbruch, Avraham
• Lee, Anne W.M.
• Lee, Victor H.F.
• Ng, Sweet Ping
• Nuyts, Sandra
• Smee, Robert
• Ferlito, Alfio

Titel

Dosimetric parameters predict radiation-induced temporal lobe necrosis in nasopharyngeal carcinoma patients: A systematic review and meta-analysis

Ist Teil von

• Radiotherapy and oncology, 2024-06, Vol.195, p.110258, Article 110258

Ort / Verlag

Ireland: Elsevier B.V

Erscheinungsjahr

2024

Quelle

Access via ScienceDirect (Elsevier)

Beschreibungen/Notizen

• •Dosimetric parameters are crucial in predicting TLN in patients with NPC.•The incidence of TLN ranged from 2.3 % to 47.3 %, with a latency period ranging from 27 to 48 months.•The threshold values for Dmax and D1cc of the temporal lobe are less than 72 Gy and 62 Gy, respectively. This systematic review examines the role of dosimetric parameters in predicting temporal lobe necrosis (TLN) risk in nasopharyngeal carcinoma (NPC) patients treated with three-dimensional conformal RT (3D-CRT), intensity-modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT). TLN is a serious late complication that can adversely affect the quality of life of NPC patients. Understanding the relationship between dosimetric parameters and TLN can guide treatment planning and minimize radiation-related complications. A comprehensive search identified relevant studies published up to July 2023. Studies reporting on dosimetric parameters and TLN in NPC patients undergoing 3D-CRT, IMRT, and VMAT were included. TLN incidence, follow-up duration, and correlation with dosimetric parameters of the temporal lobe were analyzed. The review included 30 studies with median follow-up durations ranging from 28 to 110 months. The crude incidence of TLN varied from 2.3 % to 47.3 % and the average crude incidence of TLN is approximately 14 %. Dmax and D1cc emerged as potential predictors of TLN in 3D-CRT and IMRT-treated NPC patients. Threshold values of >72 Gy for Dmax and >62 Gy for D1cc were associated with increased TLN risk. However, other factors should also be considered, including host characteristics, tumor-specific features and therapeutic factors. In conclusion, this systematic review highlights the significance of dosimetric parameters, particularly Dmax and D1cc, in predicting TLN risk in NPC patients undergoing 3D-CRT, IMRT, and VMAT. The findings provide valuable insights that can help in developing optimal treatment planning strategies and contribute to the development of clinical guidelines in this field.